CHGB
Basic information
Region (hg38): 20:5911510-5925353
Previous symbols: [ "SCG1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHGB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 37 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 37 | 4 | 8 |
Variants in CHGB
This is a list of pathogenic ClinVar variants found in the CHGB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-5911670-G-T | not specified | Uncertain significance (Feb 14, 2023) | ||
20-5911680-C-A | not specified | Uncertain significance (Apr 01, 2024) | ||
20-5916350-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
20-5916838-A-G | not specified | Uncertain significance (Feb 13, 2023) | ||
20-5916866-C-T | not specified | Uncertain significance (Jun 27, 2022) | ||
20-5916874-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
20-5916881-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
20-5922423-G-A | CHGB-related disorder | Benign (Jun 05, 2019) | ||
20-5922451-G-C | not specified | Uncertain significance (May 30, 2024) | ||
20-5922495-G-C | CHGB-related disorder | Benign (May 28, 2019) | ||
20-5922511-T-G | not specified | Uncertain significance (Oct 03, 2022) | ||
20-5922520-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
20-5922526-G-A | not specified | Uncertain significance (Apr 17, 2024) | ||
20-5922544-G-C | not specified | Uncertain significance (Aug 16, 2022) | ||
20-5922578-A-G | not specified | Uncertain significance (Oct 20, 2021) | ||
20-5922586-G-C | not specified | Uncertain significance (Aug 04, 2023) | ||
20-5922607-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
20-5922648-G-C | not specified | Uncertain significance (Jun 05, 2024) | ||
20-5922701-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
20-5922719-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
20-5922727-C-G | not specified | Uncertain significance (Feb 15, 2023) | ||
20-5922833-A-G | CHGB-related disorder | Benign (Dec 02, 2019) | ||
20-5922926-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
20-5922964-G-A | not specified | Uncertain significance (Jun 17, 2022) | ||
20-5922974-G-A | not specified | Uncertain significance (May 08, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHGB | protein_coding | protein_coding | ENST00000378961 | 5 | 13932 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.36e-7 | 0.995 | 125682 | 0 | 66 | 125748 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0840 | 358 | 363 | 0.988 | 0.0000191 | 4495 |
Missense in Polyphen | 110 | 117.76 | 0.93407 | 1636 | ||
Synonymous | -0.701 | 152 | 141 | 1.07 | 0.00000828 | 1182 |
Loss of Function | 2.54 | 16 | 31.3 | 0.511 | 0.00000182 | 374 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000368 | 0.000365 |
Ashkenazi Jewish | 0.0000996 | 0.0000992 |
East Asian | 0.000437 | 0.000435 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000301 | 0.000299 |
Middle Eastern | 0.000437 | 0.000435 |
South Asian | 0.000327 | 0.000327 |
Other | 0.000168 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Secretogranin-1 is a neuroendocrine secretory granule protein, which may be the precursor for other biologically active peptides.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.286
Intolerance Scores
- loftool
- 0.848
- rvis_EVS
- 1.94
- rvis_percentile_EVS
- 97.51
Haploinsufficiency Scores
- pHI
- 0.200
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.397
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.871
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chgb
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- regulation of signaling receptor activity;post-translational protein modification;cellular protein metabolic process
- Cellular component
- extracellular space;endoplasmic reticulum lumen;secretory granule
- Molecular function
- hormone activity;protein binding